# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Demyelinating Diseases

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-20 of 541 results.
Cognition and MRI Markers in MS Patients With Aubagio® Treatment
Status: Recruiting
Last Changed: May 18, 2020
First Received: Dec 07, 2018
Disease(s): Multiple Sclerosis, Relapsing-Remitting
Intervention(s): Clinical assessment, Ecological evaluation, Neuropsychological evaluation, Psychological evaluation, MRI Evaluation
Locations: CHU de Bordeaux - Service de neurologie, Bordeaux, France
Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP
Status: Recruiting
Last Changed: Sep 28, 2020
First Received: Sep 15, 2015
Disease(s): Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Intervention(s): HYQVIA, 0.25% albumin placebo solution with rHuPH20, IGIV
Locations: Barrow Neurological Institute, Phoenix, Arizona, United States
Arizona Neuromuscular Research Center, Phoenix, Arizona, United States
University of California-Irvine, Orange, California, United States
Forbes Norris Mda/als Ctr, San Francisco, California, United States
Regents of the University of colorado, Aurora, Colorado, United States
... and 105 other locations.
Behavior and Activity Monitoring in MS
Status: Recruiting
Last Changed: Jan 29, 2019
First Received: Aug 09, 2017
Disease(s): Relapsing-Remitting Multiple Sclerosis
Intervention(s): Step Tracking, Water Tracking
Locations: Department of Psychology, The Ohio State University, Columbus, Ohio, United States
Motor Skill Acquisition Between Individuals With Neurological Disorders and Healthy Individuals
Status: Recruiting
Last Changed: Aug 07, 2020
First Received: Aug 07, 2020
Disease(s): Stroke, Multiple Sclerosis
Intervention(s): Visuomotor leg reaching task
Locations: Texas Woman's University, Houston, Texas, United States
An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD
Status: Recruiting
Last Changed: Sep 10, 2020
First Received: Dec 17, 2019
Disease(s): Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder
Intervention(s): Ravulizumab
Locations: University of Alabama Birmingham - Multiple Sclerosis Center, Birmingham, Alabama, United States
University of South Alabama, Mobile, Alabama, United States
North County Neurology Associate, Carlsbad, California, United States
University of Colorado Hospital Anschutz Outpatient Pavilion, Aurora, Colorado, United States
Advanced Neurosciences Research, LLC, Fort Collins, Colorado, United States
... and 40 other locations.
Cognitive Remediation Augmented With Transcranial Direct Current Stimulation (tDCS)
Status: Recruiting
Last Changed: Nov 01, 2019
First Received: Feb 10, 2017
Disease(s): Multiple Sclerosis, Neurological Disorder
Intervention(s): tDCS stimulation
Locations: New York University Medical Center, New York, New York, United States
A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder
Status: Recruiting
Last Changed: Apr 20, 2020
First Received: Nov 07, 2019
Disease(s): Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder
Intervention(s): Eculizumab
Locations: Meridian Clinical Research, Rockville, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Yokohama City University Medical Center, Yokohama, Japan
Seoul National University Hospital, Seoul, Korea, Republic of
Hospital Sant Joan de Deu, Barcelona, Spain
... and 1 other locations.
Epigenetic Evaluation of HAT/HDAC Activity in PBMC From Patients With Clinically Isolated Syndrome
Status: Recruiting
Last Changed: Nov 18, 2019
First Received: Aug 11, 2016
Disease(s): Demyelinating Autoimmune Diseases, CNS
Intervention(s): blood sample
Locations: University Hospital, Besançon, France
Natural History Study of Patients With Canavan Disease, CAN Inform
Status: Recruiting
Last Changed: Jul 24, 2020
First Received: Oct 14, 2019
Disease(s): Canavan Disease
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States
NYU Langone Medical Center, New York, New York, United States
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis
Status: Recruiting
Last Changed: Jan 23, 2020
First Received: May 24, 2018
Disease(s): Relapsing Remitting Multiple Sclerosis, Optic Neuropathy, Optic; Neuritis, With Demyelination
Intervention(s): CNM-Au8, Placebo
Locations: John Hunter Hospital, New Lambton Heights, New South Wales, Australia
Royal North Shore Hospital, St. Leonards, New South Wales, Australia
Sydney Brain Mind Centre, Sydney, New South Wales, Australia
Westmead Hospital, Westmead, New South Wales, Australia
Princess Alexandria Hospital, Woolloongabba, Queensland, Australia
... and 5 other locations.